Nihon Chemiphar Co., Ltd.

Nihon Chemiphar is a mid-sized pharmaceutical company that develops both new drugs and generics. Its defining feature is a dual-engine model of new drugs and generics, complemented by clinical diagnostics. After many years focused on new drugs, it made a full-scale entry into generics in 2000 and built an integrated operation from development through manufacturing and sales. It also operates clinical diagnostics businesses for allergies and lifestyle-related diseases, as well as healthcare businesses. The company therefore spans new drugs, generics, and diagnostic products, and is headquartered in Chiyoda, Tokyo.